Vanguard Group Inc. Has $128.70 Million Stake in Core Laboratories Inc. (NYSE:CLB)

Vanguard Group Inc. cut its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 1.4% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,360,112 shares of the oil and gas company's stock after selling 76,917 shares during the period. Vanguard Group Inc. owned approximately 11.47% of Core Laboratories worth $128,696,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of CLB. Allspring Global Investments Holdings LLC purchased a new stake in shares of Core Laboratories in the third quarter valued at approximately $31,000. State of Wyoming grew its position in shares of Core Laboratories by 43.1% in the second quarter. State of Wyoming now owns 1,447 shares of the oil and gas company's stock valued at $34,000 after purchasing an additional 436 shares in the last quarter. Tower Research Capital LLC TRC grew its position in shares of Core Laboratories by 9,913.3% in the second quarter. Tower Research Capital LLC TRC now owns 1,502 shares of the oil and gas company's stock valued at $35,000 after purchasing an additional 1,487 shares in the last quarter. UBS Group AG grew its position in shares of Core Laboratories by 171.6% in the third quarter. UBS Group AG now owns 3,200 shares of the oil and gas company's stock valued at $43,000 after purchasing an additional 2,022 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its position in shares of Core Laboratories by 184.9% in the fourth quarter. PNC Financial Services Group Inc. now owns 2,934 shares of the oil and gas company's stock valued at $59,000 after purchasing an additional 1,904 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Stifel Nicolaus lowered their price objective on Core Laboratories from $21.00 to $17.00 and set a "hold" rating for the company in a research report on Monday, February 5th. StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a research report on Saturday, January 20th. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $19.88.

Core Laboratories Stock Up 0.1 %

Shares of NYSE CLB traded up $0.01 during mid-day trading on Wednesday, hitting $17.34. The company had a trading volume of 332,743 shares, compared to its average volume of 486,049. The company has a market capitalization of $812.55 million, a PE ratio of 20.15, a price-to-earnings-growth ratio of 0.54 and a beta of 2.40. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.53 and a quick ratio of 1.72. Core Laboratories Inc. has a 1-year low of $13.82 and a 1-year high of $27.94. The business's 50-day simple moving average is $15.65 and its 200 day simple moving average is $18.35.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings data on Wednesday, January 31st. The oil and gas company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.01). Core Laboratories had a net margin of 8.03% and a return on equity of 15.19%. The company had revenue of $128.21 million during the quarter, compared to analyst estimates of $127.80 million. During the same quarter in the previous year, the business posted $0.23 earnings per share. On average, analysts predict that Core Laboratories Inc. will post 0.81 earnings per share for the current year.

Core Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 4th. Shareholders of record on Monday, February 12th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date of this dividend was Friday, February 9th. Core Laboratories's dividend payout ratio is presently 4.65%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.